OTHER GROUP COMPANIES
market

Biocon Biologics receives EU GMP certificate for new facility in Bengaluru

Biocon Biologics receives EU GMP certificate for new facility in Bengaluru

July 05, 2022 8:03 IST | capital market
Biocon announced that its subsidiary, Biocon Biologics has received a EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru, following a GMP inspection in April 2022. Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity